Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)Suresh S. Ramalingam, Claude El Kouri, Nicholas Thatcher et al.|Annals of Oncology|2013Cited by 57
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countriesCelso Arango, Jannie van der Westhuizen, Jan K. Buitelaar et al.|The Lancet Psychiatry|2021Cited by 33
A randomized phase II study of carboplatin (C) and etoposide (E) with or without pan-BCL-2 antagonist obatoclax (Ob) in extensive-stage small cell lung cancer (ES-SCLC).Corey J. Langer, M. S. Berger, István Albert et al.|Journal of Clinical Oncology|2011Cited by 19